ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

OPTI Optibiotix Health Plc

16.00
0.25 (1.59%)
26 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.25 1.59% 16.00 15.50 16.50 16.00 15.75 15.75 282,805 08:09:01
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 5.63 14.59M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 15.75p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £14.59 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 5.63.

Optibiotix Health Share Discussion Threads

Showing 19976 to 19998 of 147800 messages
Chat Pages: Latest  800  799  798  797  796  795  794  793  792  791  790  789  Older
DateSubjectAuthorDiscuss
24/1/2017
09:17
Well appears fincap the house broker have kept the lid on this and are constantly on the offer.

Have to fill the ii orders somehow.

I'm a buyer at this false retrace.

You can see the small panicked sells being mopped up.

Sm

shrewdmole
24/1/2017
09:15
Ah, I read it differently, but now you've explained - thank you ;0)
spike_1
24/1/2017
09:15
Insider trading comes with a prison sentence. I have tried to help you all ,but just get the Mickey taken out of me. Best of luck to you all. DIAMOND
diamond fibre
24/1/2017
08:47
Nothing odd about it whatsoever.
We are struggling to crack 80p. It hits it and then drops back. Be good to see the back of 80p for good. For ever
Whats odd about that spike?

judijudi
24/1/2017
08:44
JJ: 'for good' odd comment? ;0)
Best wishes - Mike

spike_1
24/1/2017
08:14
thx Someuwin... I must check the website more often, now that Opti are obviously up and running on the marketing front. GLA LTHs and new... very exiting times ahead!
nicktopten
24/1/2017
08:05
Interesting to see the mention of cancers here...
someuwin
24/1/2017
07:55
As we have cutting edge technology it is important that we "shout about" our work, and these congresses give us the perfect platform and opportunity to do so.We have the Berlin one and the associated publications to look forward to just next week!
parob
24/1/2017
07:55
Spike,
This is our year
imho

judijudi
24/1/2017
07:47
Optibiotix at the forefront of a £46b market? Therein lies the value! Pick a number?
smarner
24/1/2017
07:42
JJ: Well the last year of 'near term' has - if we believe the frustration shown on these pages - not been 'of no consequence' to most here.

Putting near term value into the company is what most of us would like just for starters!

Parob - yes an interesting 'development' which should have value!

Best wishes - Mike

spike_1
24/1/2017
07:38
Great to hear we're getting more and more global exposure placing us at the forefront of global microbiome research and product development.The fact that we can enhance the growth and health benefits of existing probiotic products already on the market, surely means a faster route to commercialisation.
parob
24/1/2017
07:32
Spike,
If your an investor, near term has no consequence. Commercial success of the products over time has
imho

judijudi
24/1/2017
07:23
Difficult to know quite how important this is. The good news is that they have clearly done trials on a number of species/strands, and will be able to demonstrate they have taken them to the point where they are robust enough and cheap enough to be commercially viable.

Unfortunately - as usual - it is difficult to put a commercial value on it in the near term?

Best wishes - Mike

spike_1
24/1/2017
07:17
Interesting :)
judijudi
24/1/2017
07:09
RNS Number : 8917U
OptiBiotix Health PLC
24 January 2017


OptiBiotix Health plc

("OptiBiotix" or the "Company")



Presentation of research at Microbiome R&D and Business Collaboration: Asia



OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that it will be presenting research data on its microbiome modulators at the Microbiome R&D and Business Collaboration Congress: Asia, in Hong Kong on the 1-2 March 2017. The conference brings together experts in all areas of microbiome research and is recognised around the world as one of theleading conferences for bringing together pharma, biotech, academic institutions and investors who are looking to develop and progress ground-breaking microbiome research into next generation products through partnering.



OptiBiotix's conference abstract and presentation covers research which demonstrates the company's ability to create designer ingredients which can modify an individual's microbiome. These studies suggest commercial potential for:-



i. The development of species or genera specific prebiotics which can selectively enhance the growth and health benefits of existing probiotic products. This new product concept, called an OptiBiotic®, has the potential to enhance probiotic health benefits and provide product differentiation in the probiotic market, a market forecast to be worth more than $46.5bn by 2020 (Markets and Markets).

ii. Designer ingredients which can modify an individual's current microbiome to improve health. These ingredients are heat resistant and stable during processing, which creates the opportunity to incorporate low cost, safe, ingredients which modulate specific elements of the microbiome in a wide range of food products.



Commenting, Stephen O'Hara, CEO of OptiBiotix said: "The ability to create designer ingredients which can modify an individual's microbiome to improve health places OptiBiotix at the forefront of global microbiome research and product development. I believe we are fast approaching the next stage in the development of the microbiome in healthcare, where scientists have the ability to precision engineer components of the microbiome to prevent, manage and treat many of today's chronic lifestyle diseases."

someuwin
23/1/2017
20:59
British Bulls signal:



Signal Update

Our system’s recommendation today is to STAY LONG. The previous BUY signal was issued on 06/01/2017, 17 days ago, when the stock price was 62.5723. Since then OPTI.L has risen by +25.06%.

Market Outlook

The bulls are in full control. The negative sentiment that led to the last bearish pattern has evaporated. Besides, the signal is suggesting to STAY LONG. It is best to follow the signal and continue to hold this security.

parob
23/1/2017
19:54
Wow, just logged on!
Fantastic.
Few pennies a day will do me nicely.
Good luck all

joyjoy13
23/1/2017
19:33
A little birdy told me Max and his GoFigure team invade Iceland tomorrow armed with goodies for their largest pharma outlets where there will be hands-on promo tour.

That little birdies was me...yes, I speak to myself in the mirror. Joking apart, it's true.

elrico
23/1/2017
19:32
Owen,
Pure genius! :)

judijudi
23/1/2017
19:30
My sentiments too Judi.
owenmo
23/1/2017
19:24
Rocket Science from Diamond
Great news coming and some exciting announcements
Never!!! :)

judijudi
23/1/2017
19:18
Diamond, based on your post I hope you haven't bought any shares today...
1bokke
Chat Pages: Latest  800  799  798  797  796  795  794  793  792  791  790  789  Older